You have access
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy
MINEHIKO INOMATA, SHUHEI MINATOYAMA, NAOKI TAKATA, KANA HAYASHI, TAKAHIRO HIRAI, ZENTA SETO, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, KEI MATSUYAMA, RYUJI HAYASHI, SHOKO MATSUI and KAZUYUKI TOBE
Anticancer Research March 2024, 44 (3) 1241-1245; DOI: https://doi.org/10.21873/anticanres.16920